BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 18068859)

  • 41. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [How I explore ... the skin functional involvement in scleroderma].
    Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
    Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scleroderma with an update about clinico-pathological correlation.
    Rongioletti F; Ferreli C; Atzori L; Bottoni U; Soda G
    G Ital Dermatol Venereol; 2018 Apr; 153(2):208-215. PubMed ID: 29368844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pesticide-induced scleroderma and early intensive immunosuppressive treatment.
    Sozeri B; Gulez N; Aksu G; Kutukculer N; Akalın T; Kandiloglu G
    Arch Environ Occup Health; 2012; 67(1):43-7. PubMed ID: 22315935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psoriasis and concomitant fibrosing disorders: lichen sclerosus, morphea, and systemic sclerosis.
    Walls AC; Qureshi AA
    J Am Acad Dermatol; 2012 Nov; 67(5):1079-83. PubMed ID: 23062897
    [No Abstract]   [Full Text] [Related]  

  • 46. Scleroderma in children.
    Zulian F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK.
    Hawley DP; Baildam EM; Amin TS; Cruikshank MK; Davidson JE; Dixon J; Martin NS; Ohlsson V; Pilkington C; Rangaraj S; Riley P; Sundaramoorthy C; Walsh J; Foster HE
    Rheumatology (Oxford); 2012 Jul; 51(7):1235-9. PubMed ID: 22344577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.
    Avouac J; Walker U; Tyndall A; Kahan A; Matucci-Cerinic M; Allanore Y; ; Miniati I; Muller A; Iannone F; Distler O; Becvar R; Sierakowsky S; Kowal-Bielecka O; Coelho P; Cabane J; Cutolo M; Shoenfeld Y; Valentini G; Rovensky J; Riemekasten G; Vlachoyiannopoulos P; Caporali R; Jiri S; Inanc M; Zimmermann Gorska I; Carreira P; Novak S; Czirjak L; Oliveira Ramos F; Jendro M; Chizzolini C; Kucharz EJ; Richter J; Cozzi F; Rozman B; Mallia CM; Gabrielli A; Farge D; Kiener HP; Schöffel D; Airo P; Wollheim F; Martinovic D; Trotta F; Jablonska S; Reich K; Bombardieri S; Siakka P; Pellerito R; Bambara LM; Morovic-Vergles J; Denton C; Hinrichs R; Van den Hoogen F; Damjanov N; Kötter I; Ortiz V; Heitmann S; Krasowska D; Seidel M; Hasler P; Van Laar JM; Kaltwasser JP; Foeldvari I; Juan Mas A; Bajocchi G; Wislowska M; Pereira Da Silva JA; Jacobsen S; Worm M; Graniger W; Kuhn A; Stankovic A; Cossutta R; Majdan M; Damjanovska Rajcevska L; Tikly M; Nasonov EL; Steinbrink K; Herrick A; Müller-Ladner U; Dinc A; Scorza R; Sondergaard K; Indiveri F; Nielsen H; Szekanecz Z; Silver RM; Antivalle M; Espinosa IB; García de la Pena Lefebvre P; Midtvedt O; Launay D; Valesini F; Tuvik P; Ionescu RM; Del Papa N; Pinto S; Wigley F; Mihai C; Sinziana Capranu M; Sunderkötter C; Jun JB; Alhasani S; Distler JH; Ton E; Soukup T; Seibold J; Zeni S; Nash P; Mouthon L; De Keyser F; Duruöz MT; Cantatore FP; Strauss G; von Mülhen CA; Pozzi MR; Eyerich K; Szechinski J; Keiserman M; Houssiau FA; Román-Ivorra JA; Krummel-Lorenz B; Aringer M; Westhovens R; Bellisai F; Mayer M; Stoeckl F; Uprus M; Volpe A; Buslau M; Yavuz S; Granel B; Valderílio Feijó A; Del Galdo F; Popa S; Zenone T; Ricardo Machado X; Pileckyte M; Stebbings S; Mathieu A; Tulli A; Tourinho T; Souza R; Acayaba de Toledo R; Stamp L; Solanki K; Veale D; Francisco Marques Neto J; Bagnato GF; Loyo E; Toloza S; Li M; Ahmed Abdel Atty Mohamed W; Cobankara V; Olas J; Salsano F; Oksel F; Tanaseanu CM; Foti R; Ancuta C; Vonk M; Caramashi P; Beretta L; Balbir A; Chiàla A; Pasalic Simic K; Ghio M; Stamenkovic B; Rednic S; Host N; Pellerito R; Hachulla E; Furst DE
    J Rheumatol; 2010 Jul; 37(7):1488-501. PubMed ID: 20551097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):217-28; quiz 229-30. PubMed ID: 21238823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Localized and systemic forms of scleroderma in adults and children .
    Atzeni F; Bardoni A; Cutolo M; Hunzelmann N; Krieg T; Martini G; Montecucco C; Olski TM; Secchi ME; Valentini G; Zulian F; Sarzi-Puttini P
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S36-45. PubMed ID: 16466623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic susceptibility to systemic sclerosis from clinical aspect to genetic factor analyses.
    Granel B; Bernard F; Chevillard C
    Eur J Intern Med; 2009 May; 20(3):242-52. PubMed ID: 19393491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammatory morphea in the context of Raynaud phenomenon.
    Abbasi N; Firoz B; Bossenbroek NM; Meehan SA; Kamino H; Franks AG
    Dermatol Online J; 2008 Oct; 14(10):11. PubMed ID: 19061610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.
    Thomas RM; Worswick S; Aleshin M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28032675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunological disorders and cytokine profile in systemic and localized sclerosis].
    Ter Arkh; 2012; 84(5):28-31. PubMed ID: 22830208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on pediatric systemic sclerosis: similarities and differences from adult disease.
    Foeldvari I
    Curr Opin Rheumatol; 2008 Sep; 20(5):608-12. PubMed ID: 18698186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma.
    Coit P; Schollaert KL; Mirizio EM; Torok KS; Sawalha AH
    Clin Immunol; 2021 Jul; 228():108756. PubMed ID: 33992755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulse oximetry in scleroderma patients: concerns.
    Garg R; Verma S
    Acta Anaesthesiol Scand; 2008 Oct; 52(9):1303-4. PubMed ID: 18823473
    [No Abstract]   [Full Text] [Related]  

  • 59. [Eosinophilic fasciitis--current database].
    Wojas-Pelc A; Wielowieyska-Szybińska D; Lipko-Godlewska S
    Pol Merkur Lekarski; 2004 Jun; 16(96):585-8. PubMed ID: 15510903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [An update on systemic sclerosis].
    Kowal-Bielecka O
    Ann Acad Med Stetin; 2010; 56 Suppl 1():80-2. PubMed ID: 21365948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.